4D Molecular Therapeutics, Inc. (FDMT) revenue

Revenue · fiscal 2025
$85.21M

4D Molecular Therapeutics, Inc. (FDMT) reported revenue of $85.21M in fiscal 2025 (the year ended December 31, 2025). That is 230194.6% higher than the $37.00K of fiscal 2024. Figures as of 18 Nov 2026, 07:08 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$85.21M
Change on fiscal 2024
+230194.6%
Growth, 5 years
+44.8% a year
Highest on record
$85.21Mfiscal 2025
Lowest on record
$37.00Kfiscal 2024
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

4D Molecular Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 44.8% a year. Across the 7 fiscal years on record (2019–2025), the highest was $85.21M in fiscal 2025 and the lowest $37.00K in fiscal 2024.

History · 7 fiscal years

Revenue by fiscal year

4D Molecular Therapeutics, Inc. revenue, year by year

4D Molecular Therapeutics, Inc. (FDMT) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$85.21M 230,194.6% up
2024$37.00K 99.8% down
2023$20.72M 562.3% up
2022$3.13M 82.7% down
2021$18.04M 35.0% up
2020$13.36M 92.0% up
2019$6.96M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on FDMT

4D Molecular Therapeutics, Inc., figure by figure

4D Molecular Therapeutics, Inc. (FDMT) overview: price, valuation and scorecard

4D Molecular Therapeutics, Inc. revenue: questions and answers

What is 4D Molecular Therapeutics, Inc.'s revenue?

4D Molecular Therapeutics, Inc. (FDMT) reported revenue of $85.21M in fiscal 2025 (the year ended December 31, 2025). That is 230194.6% higher than the $37.00K of fiscal 2024.

What is the growth rate of 4D Molecular Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 44.8% a year.

What are the highest and lowest revenue figures on record for 4D Molecular Therapeutics, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $85.21M in fiscal 2025 and the lowest $37.00K in fiscal 2024.

How is 4D Molecular Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “4D Molecular Therapeutics, Inc. (FDMT) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/FDMT/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.